Eye Healthcare Giant Bausch + Lomb Welcomes Back Brent Saunders to Lead as New CEO

AirdropSweaterFan · 2026-01-12T18:49:50+00:00

Bausch + Lomb has appointed Brent Saunders as CEO and Board Chair, effective March 6. He will begin consulting on February 16 to ensure a smooth transition from outgoing CEO Joseph C. Papa, leveraging his prior leadership experience to guide the company forward.

AirdropSweaterFan

2026-01-12 18:49:50

Abstract generation in progress

Bausch + Lomb Corporation (BLCO), a prominent player in the eye care industry, has named Brent Saunders to the role of Chief Executive Officer and Board Chair, marking his return to the organization. The leadership change becomes effective on March 6, following the planned exit of current CEO Joseph C. Papa.

In a strategic move to ensure operational continuity, Brent Saunders will commence his engagement with Bausch + Lomb two weeks ahead of the official transition date. Beginning February 16, he will serve in a consulting capacity, working closely with the existing leadership team to facilitate a seamless handover of responsibilities.

This appointment marks a significant moment for the company, as Saunders brings prior experience from his tenure at Bausch + Lomb, where he previously led the organization as Chief Executive Officer between 2010 and 2013. His return signals the company’s confidence in his strategic vision for navigating the evolving eye healthcare landscape.

The transition timeline demonstrates Bausch + Lomb’s commitment to maintaining stability while ushering in fresh leadership direction. With Brent Saunders at the helm, the company looks poised to advance its position in the competitive eye care sector.

Disclaimer: This analysis represents editorial perspective and should not be considered as financial advice or endorsement of any particular investment thesis.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.